ProfileGDS4718 / 202924_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 58% 56% 61% 66% 88% 82% 66% 60% 58% 63% 72% 66% 85% 74% 64% 63% 77% 71% 55% 66% 65% 62% 67% 63% 83% 66% 76% 71% 77% 73% 77% 65% 76% 73% 76% 82% 63% 66% 52% 70% 78% 74% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1691461
GSM549102patient 115, normal, homogenized [OPG study]6.0081558
GSM549104patient 119, normal, homogenized [OPG study]5.8421656
GSM549108patient 138, normal, homogenized [OPG study]6.2082361
GSM549119patient 077, normal, homogenized [OPG study]6.5056466
GSM549133patient 032, cancer, homogenized [OPG study]9.0004688
GSM549139patient 042, cancer, homogenized [OPG study]8.068482
GSM549099patient 107, normal, homogenized [OPG study]6.5248166
GSM549109patient 139, normal, homogenized [OPG study]6.1643360
GSM549110patient 046, normal, homogenized [OPG study]6.0060858
GSM549114patient 063, normal, homogenized [OPG study]6.3302963
GSM549122patient 082, normal, homogenized [OPG study]7.0261972
GSM549134patient 033, cancer, homogenized [OPG study]6.5416466
GSM549136patient 036, cancer, homogenized [OPG study]8.4928885
GSM549140patient 044, cancer, homogenized [OPG study]7.2601874
GSM549111patient 047, normal, homogenized [OPG study]6.4063764
GSM549113patient 057, normal, homogenized [OPG study]6.3424463
GSM549132patient 031, cancer, homogenized [OPG study]7.5726277
GSM549137patient 038, cancer, homogenized [OPG study]6.9543671
GSM549142patient 047, cancer, homogenized [OPG study]5.9486155
GSM549100patient 110, normal, homogenized [OPG study]6.5452666
GSM549107patient 135, normal, homogenized [OPG study]6.4464765
GSM549115patient 068, normal, homogenized [OPG study]6.2564662
GSM549116patient 072, normal, homogenized [OPG study]6.650667
GSM549120patient 078, normal, homogenized [OPG study]6.3562863
GSM549131patient 030, cancer, homogenized [OPG study]8.3201983
GSM549118patient 074, normal, homogenized [OPG study]6.5987666
GSM549129patient 027, cancer, homogenized [OPG study]7.5209876
GSM549123patient 088, normal, homogenized [OPG study]7.0075171
GSM549124patient 006, cancer, homogenized [OPG study]7.4400977
GSM549126patient 015, cancer, homogenized [OPG study]7.1828573
GSM549128patient 025, cancer, homogenized [OPG study]7.6403177
GSM549103patient 117, normal, homogenized [OPG study]6.4432265
GSM549117patient 073, normal, homogenized [OPG study]7.4316976
GSM549138patient 041, cancer, homogenized [OPG study]7.1633973
GSM549141patient 045, cancer, homogenized [OPG study]7.5617876
GSM549130patient 028, cancer, homogenized [OPG study]8.0494282
GSM549101patient 111, normal, homogenized [OPG study]6.3388763
GSM549105patient 128, normal, homogenized [OPG study]6.5263866
GSM549106patient 134, normal, homogenized [OPG study]5.6094552
GSM549112patient 048, normal, homogenized [OPG study]6.9003470
GSM549125patient 011, cancer, homogenized [OPG study]7.6374478
GSM549127patient 024, cancer, homogenized [OPG study]7.3638774
GSM549135patient 035, cancer, homogenized [OPG study]7.9579480